← Eichor
Study identifier: NCT06462937 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Digital Exercise Intervention in Patients With Spondyloarthritis

Condition: Spondyloarthritis · Exercise  ·  Sponsor: Diakonhjemmet Hospital

PhaseNA
Planned participants260
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This protocol describes a 6-month randomised, controlled exercise trial in patients with axial spondyloarthritis (axSpA) with re-randomization after 3-months. The primary outcome of the trial (disease activity) will be evaluated at 3-months. The exercise programme on trial comprises high intensity interval training (HIIT), muscular strength exercise and aerobic physical activity sessions of specified duration, frequency, and intensity. It also includes brief knowledge videos to empower the patient. The intervention is remotely delivered by the SPARK application with personalised follow-up including monitoring to ensure exercise progression and adherence to exercise intensity. The SPARK application is built on a platform delivered by ABEL Technologies (trademark) and is customised for patients with axSpA.

This description comes directly from the study's public registry record.

Talk to the study team

Sella A Provan, Professor  ·  4791582581  ·  SellaProvan@gmail.com

Birgitte Nellemann, PhD  ·  4747957020  ·  birgittenellemann@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Diakonhjemmet hospitalOslo, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06462937